Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia
about
From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsAn enhanced heterologous virus-like particle for human papillomavirus type 16 tumour immunotherapy.Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia.Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progressionImmune therapy for human papillomaviruses-related cancers.Immunosuppressive tumor microenvironment in cervical cancer patientsAlterations of T-cell surface markers in older women with persistent human papillomavirus infection.Peripheral blood lymphocytes from low-grade squamous intraepithelial lesions patients recognize vaccine antigens in the presence of activated dendritic cells, and produced high levels of CD8 + IFNγ + T cells and low levels of IL-2 when induced to prThe invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected womenNew Approaches to Immunotherapy for HPV Associated Cancers.Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3.Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers.Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?Toll-like receptors in human papillomavirus infection.The interplay between HPV and host immunity in head and neck squamous cell carcinoma.Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults.Natural history of high-grade cervical intraepithelial neoplasia: a review of prognostic biomarkers.Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma.Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer.Identification of promiscuous HPV16-derived T helper cell epitopes for therapeutic HPV vaccine design.Glucocorticoid-induced tumor necrosis factor receptor expression in patients with cervical human papillomavirus infection.T- and NK-cell populations with regulatory phenotype and markers of apoptosis in circulating lymphocytes of patients with CIN3 or microcarcinoma of the cervix: evidence for potential mechanisms of immune suppressionIncrease of human papillomavirus-16 E7-specific T helper type 1 response in peripheral blood of cervical cancer patients after radiotherapy.Carcinogenic human papillomavirus infection.Increased vascular endothelial growth factor expression, CD3-positive cell infiltration, and oxidative stress in premalignant lesions of the cervix.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.
P2860
Q26865532-91FBBED3-1641-4302-827A-115D9C41D45AQ31121276-8C25AB6B-AB3A-48A9-9952-7E18DED0DCA2Q33620823-FBFE170D-83C1-4880-946D-5CE8D509B203Q33638975-D1BBA393-6B2E-45DE-B77E-EA587030AE55Q34633776-72C45BD6-B9D6-4D10-8705-79027D5ACCD1Q34657561-0CD200A7-3700-49A3-945C-537AE3562DCAQ35603131-E48F0DE2-4E7A-4BFC-878E-7011A9EC4B29Q35778017-76DD2813-BA8A-4316-B1CD-C48EE23412ACQ36123196-A059C214-B5AD-4D96-BDE9-ECB9480CDDA5Q36541450-69801D6A-AEF8-4E69-8917-4EF7E2017680Q37012660-7F70A5AE-C1E8-4F70-93FF-CBF8423B47A9Q37137430-3E4592DD-1576-40F8-8B20-7F72D6225464Q37226721-3DCC83EA-A998-4C76-9A93-DA5098004C65Q37620568-F55411E4-7007-4A46-B603-6527D543512FQ37943790-C430311B-FDAC-4C8E-A16D-B206F1441BBEQ38084160-F67F5BC0-1E70-4307-A3FE-A10ECBD1E2CEQ38126455-F462B92F-3E01-4B2D-9323-EC956E795D8CQ38134426-F44C4011-58E0-4483-93B3-D47CD4540787Q38363737-8D93940A-9121-40A0-A5AC-82EAABAD0A39Q39360242-980D4D02-8CF5-4072-A53E-E8C76F770605Q39893068-DF7F9AFA-FC97-48C6-AC67-B5C880EC13DFQ42218961-E5B5272D-4AD6-4F90-97C1-03C4BF716492Q42283665-89ED42C6-2A65-499E-89AC-EC7365545598Q42682331-0654ACAF-28B6-4773-BA09-122676E8A77AQ44280889-04DDCAA2-B8AD-4F12-AD04-478CB9BC7E2EQ44863515-DB9E1A62-3F86-43F3-BDD1-B5C30603D38FQ47696294-91C3D56E-0B1B-4974-BB18-63B9D5BBCD73Q50115667-E3528145-6AD2-457E-830D-72F30F195477
P2860
Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia
description
im November 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2007
@uk
name
Frequencies and role of regula ...... e)malignant cervical neoplasia
@en
Frequencies and role of regulatory T cells in patients with
@nl
type
label
Frequencies and role of regula ...... e)malignant cervical neoplasia
@en
Frequencies and role of regulatory T cells in patients with
@nl
prefLabel
Frequencies and role of regula ...... e)malignant cervical neoplasia
@en
Frequencies and role of regulatory T cells in patients with
@nl
P2093
P2860
P1476
Frequencies and role of regula ...... e)malignant cervical neoplasia
@en
P2093
A G van der Zee
B-N Hoogenboom
D van Baarle
E Schuuring
H W Nijman
W Abdulahad
P2860
P304
P356
10.1111/J.1365-2249.2007.03468.X
P407
P577
2007-11-01T00:00:00Z